Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| GABAergic neuron | 4 studies | 22% ± 3% | |
| glutamatergic neuron | 4 studies | 27% ± 7% | |
| ciliated cell | 3 studies | 21% ± 3% | |
| neuron | 3 studies | 18% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 19% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 1887.72 | 180 / 180 | 100% | 40.71 | 430 / 430 |
| prostate | 100% | 1962.50 | 245 / 245 | 100% | 30.89 | 502 / 502 |
| skin | 100% | 1565.56 | 1809 / 1809 | 100% | 24.91 | 472 / 472 |
| thymus | 100% | 2248.50 | 653 / 653 | 100% | 26.46 | 605 / 605 |
| breast | 100% | 1458.62 | 459 / 459 | 100% | 22.51 | 1116 / 1118 |
| brain | 100% | 1051.73 | 2637 / 2642 | 100% | 20.43 | 705 / 705 |
| uterus | 100% | 1839.51 | 170 / 170 | 100% | 26.07 | 458 / 459 |
| pancreas | 100% | 898.09 | 327 / 328 | 100% | 16.13 | 178 / 178 |
| kidney | 100% | 2204.78 | 89 / 89 | 100% | 27.48 | 897 / 901 |
| esophagus | 100% | 1901.98 | 1445 / 1445 | 99% | 16.58 | 182 / 183 |
| lung | 100% | 1120.36 | 576 / 578 | 100% | 22.43 | 1151 / 1155 |
| intestine | 100% | 1818.77 | 966 / 966 | 99% | 18.09 | 523 / 527 |
| bladder | 100% | 2282.86 | 21 / 21 | 99% | 22.22 | 500 / 504 |
| stomach | 100% | 1359.43 | 359 / 359 | 99% | 17.07 | 283 / 286 |
| adrenal gland | 100% | 2096.07 | 258 / 258 | 94% | 11.47 | 217 / 230 |
| liver | 96% | 455.94 | 216 / 226 | 92% | 12.07 | 375 / 406 |
| adipose | 100% | 1227.95 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1393.36 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 23.75 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 13.97 | 29 / 29 |
| spleen | 100% | 1082.10 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 20.05 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 15.99 | 1 / 1 |
| muscle | 95% | 542.26 | 764 / 803 | 0% | 0 | 0 / 0 |
| heart | 94% | 616.17 | 807 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 85% | 631.84 | 787 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051607 | Biological process | defense response to virus |
| GO_0035609 | Biological process | C-terminal protein deglutamylation |
| GO_0006508 | Biological process | proteolysis |
| GO_0035610 | Biological process | protein side chain deglutamylation |
| GO_0035611 | Biological process | protein branching point deglutamylation |
| GO_0035608 | Biological process | protein deglutamylation |
| GO_0030496 | Cellular component | midbody |
| GO_0005829 | Cellular component | cytosol |
| GO_0015630 | Cellular component | microtubule cytoskeleton |
| GO_0045171 | Cellular component | intercellular bridge |
| GO_0072686 | Cellular component | mitotic spindle |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0004181 | Molecular function | metallocarboxypeptidase activity |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0015631 | Molecular function | tubulin binding |
| Gene name | AGBL5 |
| Protein name | Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (EC 3.4.17.24) (ATP/GTP-binding protein-like 5) (Protein deglutamylase CCP5) AGBL carboxypeptidase 5 |
| Synonyms | CCP5 |
| Description | FUNCTION: Metallocarboxypeptidase that mediates deglutamylation of tubulin and non-tubulin target proteins. Catalyzes the removal of polyglutamate side chains present on the gamma-carboxyl group of glutamate residues within the C-terminal tail of alpha- and beta-tubulin. Cleaves alpha- and gamma-linked polyglutamate tubulin side-chain, as well as the branching point glutamate. Also catalyzes the removal of alpha-linked glutamate residues from the carboxy-terminus of alpha-tubulin. Mediates deglutamylation of nucleotidyltransferase CGAS, leading to CGAS antiviral defense response activation. . |
| Accessions | C9JHM6 ENST00000437006.1 ENST00000451003.5 ENST00000453161.5 ENST00000441931.1 H7C1L5 ENST00000323064.12 [Q8NDL9-3] Q8NDL9 ENST00000487078.5 [Q8NDL9-2] ENST00000421915.5 C9JCE1 C9JTY1 ENST00000360131.5 [Q8NDL9-1] C9JQG9 |